Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1111-1120 of 10934

Edit search filters
  1. Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

  2. Spasticity After Spinal Cord Injury

    Rochester, MN

  3. Treating Epilepsy With Transcranial Direct Current Stimulation

    Rochester, MN

  4. Full-Time Occlusion Therapy for Intermittent Exotropia in Children (IXT7)

    Rochester, MN

  5. A Study to Evaluate Setmelanoitide to Treat Patients with Rare Genetic Disorders of Obesity

    Rochester, MN

  6. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS

    Rochester, MN

  7. Determining the Effectiveness of the Sphenopalatine Ganglion (SPG) Block for the Treatment of the Postdural Puncture Headache

    Rochester, MN

  8. Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous use) in Patients with Primary Hyperoxaluria - PHYOX 2

    Rochester, MN

  9. A Study to Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with Amyotrophic Lateral Sclerosis (ALS)

    Jacksonville, FL

  10. An Extension Study to Assess Long-Term Safety of Eplontersen in Adults with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer